nodes	percent_of_prediction	percent_of_DWPC	metapath
Vorinostat—HDAC11—hematopoietic system—stomach cancer	0.00715	0.0325	CbGeAlD
Vorinostat—NCOR1—hematopoietic system—stomach cancer	0.00693	0.0315	CbGeAlD
Vorinostat—HDAC2—Topotecan—Irinotecan—stomach cancer	0.00669	1	CbGdCrCtD
Vorinostat—HDAC3—hematopoietic system—stomach cancer	0.00608	0.0276	CbGeAlD
Vorinostat—HDAC8—digestive system—stomach cancer	0.0057	0.0259	CbGeAlD
Vorinostat—HDAC1—hematopoietic system—stomach cancer	0.00557	0.0253	CbGeAlD
Vorinostat—HDAC9—hematopoietic system—stomach cancer	0.00548	0.0249	CbGeAlD
Vorinostat—HDAC6—endocrine gland—stomach cancer	0.00531	0.0241	CbGeAlD
Vorinostat—HDAC8—bone marrow—stomach cancer	0.00525	0.0239	CbGeAlD
Vorinostat—HDAC4—bone marrow—stomach cancer	0.00511	0.0232	CbGeAlD
Vorinostat—HDAC1—epithelium—stomach cancer	0.00509	0.0231	CbGeAlD
Vorinostat—HDAC11—lymphoid tissue—stomach cancer	0.00503	0.0229	CbGeAlD
Vorinostat—HDAC11—digestive system—stomach cancer	0.00497	0.0226	CbGeAlD
Vorinostat—HDAC3—pancreas—stomach cancer	0.00495	0.0225	CbGeAlD
Vorinostat—HDAC1—smooth muscle tissue—stomach cancer	0.0049	0.0223	CbGeAlD
Vorinostat—NCOR1—lymphoid tissue—stomach cancer	0.00488	0.0222	CbGeAlD
Vorinostat—NCOR1—digestive system—stomach cancer	0.00482	0.0219	CbGeAlD
Vorinostat—HDAC6—liver—stomach cancer	0.00479	0.0218	CbGeAlD
Vorinostat—HDAC4—endocrine gland—stomach cancer	0.00458	0.0208	CbGeAlD
Vorinostat—HDAC1—pancreas—stomach cancer	0.00453	0.0206	CbGeAlD
Vorinostat—HDAC9—pancreas—stomach cancer	0.00446	0.0203	CbGeAlD
Vorinostat—NCOR1—bone marrow—stomach cancer	0.00445	0.0202	CbGeAlD
Vorinostat—HDAC3—lymphoid tissue—stomach cancer	0.00428	0.0194	CbGeAlD
Vorinostat—HDAC8—liver—stomach cancer	0.00425	0.0193	CbGeAlD
Vorinostat—HDAC3—digestive system—stomach cancer	0.00423	0.0192	CbGeAlD
Vorinostat—HDAC4—liver—stomach cancer	0.00413	0.0187	CbGeAlD
Vorinostat—HDAC11—endocrine gland—stomach cancer	0.00411	0.0187	CbGeAlD
Vorinostat—NCOR1—endocrine gland—stomach cancer	0.00398	0.0181	CbGeAlD
Vorinostat—HDAC1—lymphoid tissue—stomach cancer	0.00392	0.0178	CbGeAlD
Vorinostat—HDAC3—bone marrow—stomach cancer	0.0039	0.0177	CbGeAlD
Vorinostat—HDAC1—digestive system—stomach cancer	0.00387	0.0176	CbGeAlD
Vorinostat—HDAC9—lymphoid tissue—stomach cancer	0.00385	0.0175	CbGeAlD
Vorinostat—NR0B1—endocrine gland—stomach cancer	0.00374	0.017	CbGeAlD
Vorinostat—HDAC6—lymph node—stomach cancer	0.00367	0.0167	CbGeAlD
Vorinostat—NCOR1—liver—stomach cancer	0.00359	0.0163	CbGeAlD
Vorinostat—HDAC1—bone marrow—stomach cancer	0.00357	0.0162	CbGeAlD
Vorinostat—HDAC9—bone marrow—stomach cancer	0.00351	0.0159	CbGeAlD
Vorinostat—HDAC3—endocrine gland—stomach cancer	0.00349	0.0159	CbGeAlD
Vorinostat—HDAC8—lymph node—stomach cancer	0.00326	0.0148	CbGeAlD
Vorinostat—HDAC1—endocrine gland—stomach cancer	0.0032	0.0145	CbGeAlD
Vorinostat—HDAC4—lymph node—stomach cancer	0.00316	0.0144	CbGeAlD
Vorinostat—HDAC3—liver—stomach cancer	0.00315	0.0143	CbGeAlD
Vorinostat—HDAC1—liver—stomach cancer	0.00288	0.0131	CbGeAlD
Vorinostat—HDAC11—lymph node—stomach cancer	0.00284	0.0129	CbGeAlD
Vorinostat—HDAC2—hematopoietic system—stomach cancer	0.0028	0.0127	CbGeAlD
Vorinostat—NCOR1—lymph node—stomach cancer	0.00275	0.0125	CbGeAlD
Vorinostat—HDAC2—epithelium—stomach cancer	0.00256	0.0116	CbGeAlD
Vorinostat—HDAC2—smooth muscle tissue—stomach cancer	0.00247	0.0112	CbGeAlD
Vorinostat—HDAC3—lymph node—stomach cancer	0.00241	0.011	CbGeAlD
Vorinostat—HDAC2—pancreas—stomach cancer	0.00228	0.0104	CbGeAlD
Vorinostat—HDAC1—lymph node—stomach cancer	0.00221	0.01	CbGeAlD
Vorinostat—HDAC9—lymph node—stomach cancer	0.00217	0.00988	CbGeAlD
Vorinostat—HDAC2—lymphoid tissue—stomach cancer	0.00197	0.00895	CbGeAlD
Vorinostat—HDAC2—digestive system—stomach cancer	0.00195	0.00884	CbGeAlD
Vorinostat—HDAC2—bone marrow—stomach cancer	0.00179	0.00815	CbGeAlD
Vorinostat—HDAC2—endocrine gland—stomach cancer	0.00161	0.00731	CbGeAlD
Vorinostat—HDAC2—liver—stomach cancer	0.00145	0.00659	CbGeAlD
Vorinostat—HDAC2—lymph node—stomach cancer	0.00111	0.00505	CbGeAlD
Vorinostat—Nausea—Floxuridine—stomach cancer	0.000993	0.00357	CcSEcCtD
Vorinostat—Sepsis—Docetaxel—stomach cancer	0.000958	0.00344	CcSEcCtD
Vorinostat—Asthenia—Mitomycin—stomach cancer	0.000941	0.00338	CcSEcCtD
Vorinostat—Abscess—Epirubicin—stomach cancer	0.000941	0.00338	CcSEcCtD
Vorinostat—Neutropenia—Irinotecan—stomach cancer	0.000937	0.00337	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Irinotecan—stomach cancer	0.000931	0.00335	CcSEcCtD
Vorinostat—Sepsis—Capecitabine—stomach cancer	0.000927	0.00333	CcSEcCtD
Vorinostat—Pancytopenia—Fluorouracil—stomach cancer	0.000911	0.00327	CcSEcCtD
Vorinostat—Weight decreased—Irinotecan—stomach cancer	0.000906	0.00326	CcSEcCtD
Vorinostat—Proteinuria—Methotrexate—stomach cancer	0.000905	0.00325	CcSEcCtD
Vorinostat—Diarrhoea—Mitomycin—stomach cancer	0.000897	0.00323	CcSEcCtD
Vorinostat—Protein urine present—Methotrexate—stomach cancer	0.000893	0.00321	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Fluorouracil—stomach cancer	0.000892	0.0032	CcSEcCtD
Vorinostat—Acute coronary syndrome—Irinotecan—stomach cancer	0.00088	0.00316	CcSEcCtD
Vorinostat—Myocardial infarction—Irinotecan—stomach cancer	0.000875	0.00315	CcSEcCtD
Vorinostat—Neoplasm malignant—Epirubicin—stomach cancer	0.000872	0.00313	CcSEcCtD
Vorinostat—Abscess—Doxorubicin—stomach cancer	0.00087	0.00313	CcSEcCtD
Vorinostat—Dizziness—Mitomycin—stomach cancer	0.000867	0.00312	CcSEcCtD
Vorinostat—Acute coronary syndrome—Fluorouracil—stomach cancer	0.000843	0.00303	CcSEcCtD
Vorinostat—Myocardial infarction—Fluorouracil—stomach cancer	0.000838	0.00301	CcSEcCtD
Vorinostat—Vomiting—Mitomycin—stomach cancer	0.000834	0.003	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Capecitabine—stomach cancer	0.000822	0.00295	CcSEcCtD
Vorinostat—Headache—Mitomycin—stomach cancer	0.000822	0.00295	CcSEcCtD
Vorinostat—Lethargy—Docetaxel—stomach cancer	0.000817	0.00294	CcSEcCtD
Vorinostat—Neoplasm malignant—Doxorubicin—stomach cancer	0.000807	0.0029	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Docetaxel—stomach cancer	0.000801	0.00288	CcSEcCtD
Vorinostat—Pulmonary embolism—Methotrexate—stomach cancer	0.000795	0.00286	CcSEcCtD
Vorinostat—Lethargy—Capecitabine—stomach cancer	0.000791	0.00284	CcSEcCtD
Vorinostat—Nausea—Mitomycin—stomach cancer	0.000779	0.0028	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Capecitabine—stomach cancer	0.000776	0.00279	CcSEcCtD
Vorinostat—Dehydration—Docetaxel—stomach cancer	0.000745	0.00268	CcSEcCtD
Vorinostat—Pulmonary embolism—Epirubicin—stomach cancer	0.000744	0.00268	CcSEcCtD
Vorinostat—Blood creatinine increased—Capecitabine—stomach cancer	0.000727	0.00261	CcSEcCtD
Vorinostat—Dehydration—Capecitabine—stomach cancer	0.000721	0.00259	CcSEcCtD
Vorinostat—Chills—Irinotecan—stomach cancer	0.000719	0.00259	CcSEcCtD
Vorinostat—Alopecia—Irinotecan—stomach cancer	0.000708	0.00255	CcSEcCtD
Vorinostat—Hypokalaemia—Capecitabine—stomach cancer	0.000706	0.00254	CcSEcCtD
Vorinostat—Sepsis—Methotrexate—stomach cancer	0.00069	0.00248	CcSEcCtD
Vorinostat—Pulmonary embolism—Doxorubicin—stomach cancer	0.000689	0.00248	CcSEcCtD
Vorinostat—Alopecia—Fluorouracil—stomach cancer	0.000678	0.00244	CcSEcCtD
Vorinostat—Muscle spasms—Irinotecan—stomach cancer	0.000671	0.00241	CcSEcCtD
Vorinostat—Pancytopenia—Docetaxel—stomach cancer	0.000658	0.00236	CcSEcCtD
Vorinostat—Neutropenia—Docetaxel—stomach cancer	0.000647	0.00233	CcSEcCtD
Vorinostat—Sepsis—Epirubicin—stomach cancer	0.000646	0.00232	CcSEcCtD
Vorinostat—Anaemia—Irinotecan—stomach cancer	0.000645	0.00232	CcSEcCtD
Vorinostat—Pancytopenia—Capecitabine—stomach cancer	0.000637	0.00229	CcSEcCtD
Vorinostat—Neutropenia—Capecitabine—stomach cancer	0.000627	0.00225	CcSEcCtD
Vorinostat—Weight decreased—Docetaxel—stomach cancer	0.000626	0.00225	CcSEcCtD
Vorinostat—Syncope—Irinotecan—stomach cancer	0.000626	0.00225	CcSEcCtD
Vorinostat—Leukopenia—Irinotecan—stomach cancer	0.000625	0.00225	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Capecitabine—stomach cancer	0.000623	0.00224	CcSEcCtD
Vorinostat—Anaemia—Fluorouracil—stomach cancer	0.000618	0.00222	CcSEcCtD
Vorinostat—Loss of consciousness—Irinotecan—stomach cancer	0.000613	0.0022	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Methotrexate—stomach cancer	0.000612	0.0022	CcSEcCtD
Vorinostat—Cough—Irinotecan—stomach cancer	0.000609	0.00219	CcSEcCtD
Vorinostat—Acute coronary syndrome—Docetaxel—stomach cancer	0.000609	0.00219	CcSEcCtD
Vorinostat—Weight decreased—Capecitabine—stomach cancer	0.000606	0.00218	CcSEcCtD
Vorinostat—Myocardial infarction—Docetaxel—stomach cancer	0.000605	0.00218	CcSEcCtD
Vorinostat—Hyperglycaemia—Capecitabine—stomach cancer	0.000605	0.00217	CcSEcCtD
Vorinostat—Leukopenia—Fluorouracil—stomach cancer	0.000598	0.00215	CcSEcCtD
Vorinostat—Sepsis—Doxorubicin—stomach cancer	0.000598	0.00215	CcSEcCtD
Vorinostat—Acute coronary syndrome—Capecitabine—stomach cancer	0.000589	0.00212	CcSEcCtD
Vorinostat—Lethargy—Methotrexate—stomach cancer	0.000589	0.00212	CcSEcCtD
Vorinostat—Myocardial infarction—Capecitabine—stomach cancer	0.000586	0.00211	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Epirubicin—stomach cancer	0.000573	0.00206	CcSEcCtD
Vorinostat—Chest pain—Fluorouracil—stomach cancer	0.000569	0.00205	CcSEcCtD
Vorinostat—Infection—Irinotecan—stomach cancer	0.000566	0.00203	CcSEcCtD
Vorinostat—Shock—Irinotecan—stomach cancer	0.00056	0.00201	CcSEcCtD
Vorinostat—Thrombocytopenia—Irinotecan—stomach cancer	0.000558	0.002	CcSEcCtD
Vorinostat—Lethargy—Epirubicin—stomach cancer	0.000551	0.00198	CcSEcCtD
Vorinostat—Oedema peripheral—Docetaxel—stomach cancer	0.000546	0.00196	CcSEcCtD
Vorinostat—Anorexia—Irinotecan—stomach cancer	0.000543	0.00195	CcSEcCtD
Vorinostat—Infection—Fluorouracil—stomach cancer	0.000542	0.00195	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Epirubicin—stomach cancer	0.00054	0.00194	CcSEcCtD
Vorinostat—Thrombocytopenia—Fluorouracil—stomach cancer	0.000534	0.00192	CcSEcCtD
Vorinostat—Dermatitis exfoliative—Doxorubicin—stomach cancer	0.00053	0.0019	CcSEcCtD
Vorinostat—Oedema peripheral—Capecitabine—stomach cancer	0.000529	0.0019	CcSEcCtD
Vorinostat—Anorexia—Fluorouracil—stomach cancer	0.00052	0.00187	CcSEcCtD
Vorinostat—Lethargy—Doxorubicin—stomach cancer	0.00051	0.00183	CcSEcCtD
Vorinostat—Blood creatinine increased—Epirubicin—stomach cancer	0.000506	0.00182	CcSEcCtD
Vorinostat—Dehydration—Epirubicin—stomach cancer	0.000502	0.00181	CcSEcCtD
Vorinostat—Gastrointestinal haemorrhage—Doxorubicin—stomach cancer	0.0005	0.0018	CcSEcCtD
Vorinostat—Chills—Docetaxel—stomach cancer	0.000497	0.00179	CcSEcCtD
Vorinostat—Decreased appetite—Irinotecan—stomach cancer	0.000495	0.00178	CcSEcCtD
Vorinostat—Hypokalaemia—Epirubicin—stomach cancer	0.000492	0.00177	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Irinotecan—stomach cancer	0.000492	0.00177	CcSEcCtD
Vorinostat—Fatigue—Irinotecan—stomach cancer	0.000491	0.00176	CcSEcCtD
Vorinostat—Alopecia—Docetaxel—stomach cancer	0.00049	0.00176	CcSEcCtD
Vorinostat—Constipation—Irinotecan—stomach cancer	0.000487	0.00175	CcSEcCtD
Vorinostat—Chills—Capecitabine—stomach cancer	0.000481	0.00173	CcSEcCtD
Vorinostat—Decreased appetite—Fluorouracil—stomach cancer	0.000474	0.0017	CcSEcCtD
Vorinostat—Alopecia—Capecitabine—stomach cancer	0.000474	0.0017	CcSEcCtD
Vorinostat—Pancytopenia—Methotrexate—stomach cancer	0.000474	0.0017	CcSEcCtD
Vorinostat—Dysgeusia—Docetaxel—stomach cancer	0.000472	0.0017	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Fluorouracil—stomach cancer	0.000471	0.00169	CcSEcCtD
Vorinostat—Blood creatinine increased—Doxorubicin—stomach cancer	0.000468	0.00168	CcSEcCtD
Vorinostat—Neutropenia—Methotrexate—stomach cancer	0.000467	0.00168	CcSEcCtD
Vorinostat—Dehydration—Doxorubicin—stomach cancer	0.000465	0.00167	CcSEcCtD
Vorinostat—Muscle spasms—Docetaxel—stomach cancer	0.000464	0.00167	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Methotrexate—stomach cancer	0.000464	0.00167	CcSEcCtD
Vorinostat—Dysgeusia—Capecitabine—stomach cancer	0.000457	0.00164	CcSEcCtD
Vorinostat—Hypokalaemia—Doxorubicin—stomach cancer	0.000455	0.00164	CcSEcCtD
Vorinostat—Body temperature increased—Irinotecan—stomach cancer	0.00045	0.00162	CcSEcCtD
Vorinostat—Muscle spasms—Capecitabine—stomach cancer	0.000449	0.00161	CcSEcCtD
Vorinostat—Anaemia—Docetaxel—stomach cancer	0.000446	0.0016	CcSEcCtD
Vorinostat—Pancytopenia—Epirubicin—stomach cancer	0.000443	0.00159	CcSEcCtD
Vorinostat—Neutropenia—Epirubicin—stomach cancer	0.000437	0.00157	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Epirubicin—stomach cancer	0.000434	0.00156	CcSEcCtD
Vorinostat—Syncope—Docetaxel—stomach cancer	0.000433	0.00155	CcSEcCtD
Vorinostat—Leukopenia—Docetaxel—stomach cancer	0.000432	0.00155	CcSEcCtD
Vorinostat—Anaemia—Capecitabine—stomach cancer	0.000432	0.00155	CcSEcCtD
Vorinostat—Body temperature increased—Fluorouracil—stomach cancer	0.000431	0.00155	CcSEcCtD
Vorinostat—Loss of consciousness—Docetaxel—stomach cancer	0.000424	0.00152	CcSEcCtD
Vorinostat—Weight decreased—Epirubicin—stomach cancer	0.000422	0.00152	CcSEcCtD
Vorinostat—Hyperglycaemia—Epirubicin—stomach cancer	0.000421	0.00151	CcSEcCtD
Vorinostat—Cough—Docetaxel—stomach cancer	0.000421	0.00151	CcSEcCtD
Vorinostat—Syncope—Capecitabine—stomach cancer	0.000419	0.00151	CcSEcCtD
Vorinostat—Leukopenia—Capecitabine—stomach cancer	0.000418	0.0015	CcSEcCtD
Vorinostat—Chest pain—Docetaxel—stomach cancer	0.000411	0.00148	CcSEcCtD
Vorinostat—Loss of consciousness—Capecitabine—stomach cancer	0.000411	0.00148	CcSEcCtD
Vorinostat—Pancytopenia—Doxorubicin—stomach cancer	0.00041	0.00147	CcSEcCtD
Vorinostat—Asthenia—Irinotecan—stomach cancer	0.000409	0.00147	CcSEcCtD
Vorinostat—Cough—Capecitabine—stomach cancer	0.000408	0.00146	CcSEcCtD
Vorinostat—Neutropenia—Doxorubicin—stomach cancer	0.000404	0.00145	CcSEcCtD
Vorinostat—Dry mouth—Docetaxel—stomach cancer	0.000402	0.00144	CcSEcCtD
Vorinostat—Upper respiratory tract infection—Doxorubicin—stomach cancer	0.000402	0.00144	CcSEcCtD
Vorinostat—Chest pain—Capecitabine—stomach cancer	0.000398	0.00143	CcSEcCtD
Vorinostat—Infection—Docetaxel—stomach cancer	0.000391	0.00141	CcSEcCtD
Vorinostat—Weight decreased—Doxorubicin—stomach cancer	0.000391	0.00141	CcSEcCtD
Vorinostat—Hyperglycaemia—Doxorubicin—stomach cancer	0.00039	0.0014	CcSEcCtD
Vorinostat—Diarrhoea—Irinotecan—stomach cancer	0.00039	0.0014	CcSEcCtD
Vorinostat—Dry mouth—Capecitabine—stomach cancer	0.000389	0.0014	CcSEcCtD
Vorinostat—Shock—Docetaxel—stomach cancer	0.000387	0.00139	CcSEcCtD
Vorinostat—Pruritus—Fluorouracil—stomach cancer	0.000386	0.00139	CcSEcCtD
Vorinostat—Thrombocytopenia—Docetaxel—stomach cancer	0.000385	0.00139	CcSEcCtD
Vorinostat—Infection—Capecitabine—stomach cancer	0.000379	0.00136	CcSEcCtD
Vorinostat—Dizziness—Irinotecan—stomach cancer	0.000377	0.00135	CcSEcCtD
Vorinostat—Anorexia—Docetaxel—stomach cancer	0.000375	0.00135	CcSEcCtD
Vorinostat—Shock—Capecitabine—stomach cancer	0.000375	0.00135	CcSEcCtD
Vorinostat—Diarrhoea—Fluorouracil—stomach cancer	0.000373	0.00134	CcSEcCtD
Vorinostat—Thrombocytopenia—Capecitabine—stomach cancer	0.000373	0.00134	CcSEcCtD
Vorinostat—Oedema peripheral—Epirubicin—stomach cancer	0.000368	0.00132	CcSEcCtD
Vorinostat—Anorexia—Capecitabine—stomach cancer	0.000363	0.00131	CcSEcCtD
Vorinostat—Vomiting—Irinotecan—stomach cancer	0.000362	0.0013	CcSEcCtD
Vorinostat—Dizziness—Fluorouracil—stomach cancer	0.000361	0.0013	CcSEcCtD
Vorinostat—Chills—Methotrexate—stomach cancer	0.000358	0.00129	CcSEcCtD
Vorinostat—Headache—Irinotecan—stomach cancer	0.000357	0.00128	CcSEcCtD
Vorinostat—Alopecia—Methotrexate—stomach cancer	0.000353	0.00127	CcSEcCtD
Vorinostat—Vomiting—Fluorouracil—stomach cancer	0.000347	0.00125	CcSEcCtD
Vorinostat—Decreased appetite—Docetaxel—stomach cancer	0.000342	0.00123	CcSEcCtD
Vorinostat—Headache—Fluorouracil—stomach cancer	0.000342	0.00123	CcSEcCtD
Vorinostat—Oedema peripheral—Doxorubicin—stomach cancer	0.000341	0.00122	CcSEcCtD
Vorinostat—Dysgeusia—Methotrexate—stomach cancer	0.00034	0.00122	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Docetaxel—stomach cancer	0.00034	0.00122	CcSEcCtD
Vorinostat—Fatigue—Docetaxel—stomach cancer	0.000339	0.00122	CcSEcCtD
Vorinostat—Nausea—Irinotecan—stomach cancer	0.000338	0.00122	CcSEcCtD
Vorinostat—Constipation—Docetaxel—stomach cancer	0.000337	0.00121	CcSEcCtD
Vorinostat—Chills—Epirubicin—stomach cancer	0.000335	0.00121	CcSEcCtD
Vorinostat—Decreased appetite—Capecitabine—stomach cancer	0.000331	0.00119	CcSEcCtD
Vorinostat—Alopecia—Epirubicin—stomach cancer	0.00033	0.00119	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Capecitabine—stomach cancer	0.000329	0.00118	CcSEcCtD
Vorinostat—Fatigue—Capecitabine—stomach cancer	0.000329	0.00118	CcSEcCtD
Vorinostat—Constipation—Capecitabine—stomach cancer	0.000326	0.00117	CcSEcCtD
Vorinostat—Nausea—Fluorouracil—stomach cancer	0.000324	0.00116	CcSEcCtD
Vorinostat—Anaemia—Methotrexate—stomach cancer	0.000321	0.00116	CcSEcCtD
Vorinostat—Dysgeusia—Epirubicin—stomach cancer	0.000319	0.00115	CcSEcCtD
Vorinostat—Muscle spasms—Epirubicin—stomach cancer	0.000313	0.00112	CcSEcCtD
Vorinostat—Body temperature increased—Docetaxel—stomach cancer	0.000311	0.00112	CcSEcCtD
Vorinostat—Leukopenia—Methotrexate—stomach cancer	0.000311	0.00112	CcSEcCtD
Vorinostat—Chills—Doxorubicin—stomach cancer	0.00031	0.00112	CcSEcCtD
Vorinostat—Alopecia—Doxorubicin—stomach cancer	0.000306	0.0011	CcSEcCtD
Vorinostat—Cough—Methotrexate—stomach cancer	0.000303	0.00109	CcSEcCtD
Vorinostat—Body temperature increased—Capecitabine—stomach cancer	0.000301	0.00108	CcSEcCtD
Vorinostat—Anaemia—Epirubicin—stomach cancer	0.000301	0.00108	CcSEcCtD
Vorinostat—Chest pain—Methotrexate—stomach cancer	0.000296	0.00106	CcSEcCtD
Vorinostat—Dysgeusia—Doxorubicin—stomach cancer	0.000295	0.00106	CcSEcCtD
Vorinostat—Syncope—Epirubicin—stomach cancer	0.000292	0.00105	CcSEcCtD
Vorinostat—Leukopenia—Epirubicin—stomach cancer	0.000291	0.00105	CcSEcCtD
Vorinostat—Muscle spasms—Doxorubicin—stomach cancer	0.000289	0.00104	CcSEcCtD
Vorinostat—Loss of consciousness—Epirubicin—stomach cancer	0.000286	0.00103	CcSEcCtD
Vorinostat—Cough—Epirubicin—stomach cancer	0.000284	0.00102	CcSEcCtD
Vorinostat—Asthenia—Docetaxel—stomach cancer	0.000282	0.00102	CcSEcCtD
Vorinostat—Infection—Methotrexate—stomach cancer	0.000282	0.00101	CcSEcCtD
Vorinostat—Pruritus—Docetaxel—stomach cancer	0.000279	0.001	CcSEcCtD
Vorinostat—Anaemia—Doxorubicin—stomach cancer	0.000278	0.001	CcSEcCtD
Vorinostat—Thrombocytopenia—Methotrexate—stomach cancer	0.000278	0.000999	CcSEcCtD
Vorinostat—Chest pain—Epirubicin—stomach cancer	0.000277	0.000996	CcSEcCtD
Vorinostat—Asthenia—Capecitabine—stomach cancer	0.000273	0.000983	CcSEcCtD
Vorinostat—Dry mouth—Epirubicin—stomach cancer	0.000271	0.000974	CcSEcCtD
Vorinostat—Anorexia—Methotrexate—stomach cancer	0.00027	0.000972	CcSEcCtD
Vorinostat—Syncope—Doxorubicin—stomach cancer	0.00027	0.00097	CcSEcCtD
Vorinostat—Pruritus—Capecitabine—stomach cancer	0.00027	0.000969	CcSEcCtD
Vorinostat—Leukopenia—Doxorubicin—stomach cancer	0.000269	0.000969	CcSEcCtD
Vorinostat—Diarrhoea—Docetaxel—stomach cancer	0.000269	0.000968	CcSEcCtD
Vorinostat—Loss of consciousness—Doxorubicin—stomach cancer	0.000265	0.000951	CcSEcCtD
Vorinostat—Infection—Epirubicin—stomach cancer	0.000264	0.000948	CcSEcCtD
Vorinostat—Cough—Doxorubicin—stomach cancer	0.000263	0.000944	CcSEcCtD
Vorinostat—Shock—Epirubicin—stomach cancer	0.000261	0.000939	CcSEcCtD
Vorinostat—Diarrhoea—Capecitabine—stomach cancer	0.000261	0.000937	CcSEcCtD
Vorinostat—Dizziness—Docetaxel—stomach cancer	0.00026	0.000936	CcSEcCtD
Vorinostat—Thrombocytopenia—Epirubicin—stomach cancer	0.00026	0.000935	CcSEcCtD
Vorinostat—Chest pain—Doxorubicin—stomach cancer	0.000256	0.000921	CcSEcCtD
Vorinostat—Anorexia—Epirubicin—stomach cancer	0.000253	0.00091	CcSEcCtD
Vorinostat—Dizziness—Capecitabine—stomach cancer	0.000252	0.000906	CcSEcCtD
Vorinostat—Dry mouth—Doxorubicin—stomach cancer	0.000251	0.000901	CcSEcCtD
Vorinostat—Vomiting—Docetaxel—stomach cancer	0.00025	0.0009	CcSEcCtD
Vorinostat—Decreased appetite—Methotrexate—stomach cancer	0.000247	0.000887	CcSEcCtD
Vorinostat—Headache—Docetaxel—stomach cancer	0.000247	0.000887	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Methotrexate—stomach cancer	0.000245	0.000881	CcSEcCtD
Vorinostat—Fatigue—Methotrexate—stomach cancer	0.000245	0.000879	CcSEcCtD
Vorinostat—Infection—Doxorubicin—stomach cancer	0.000244	0.000877	CcSEcCtD
Vorinostat—Vomiting—Capecitabine—stomach cancer	0.000242	0.000871	CcSEcCtD
Vorinostat—Shock—Doxorubicin—stomach cancer	0.000242	0.000869	CcSEcCtD
Vorinostat—Thrombocytopenia—Doxorubicin—stomach cancer	0.000241	0.000865	CcSEcCtD
Vorinostat—Headache—Capecitabine—stomach cancer	0.000239	0.000858	CcSEcCtD
Vorinostat—Anorexia—Doxorubicin—stomach cancer	0.000234	0.000842	CcSEcCtD
Vorinostat—Nausea—Docetaxel—stomach cancer	0.000234	0.000841	CcSEcCtD
Vorinostat—Decreased appetite—Epirubicin—stomach cancer	0.000231	0.00083	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Epirubicin—stomach cancer	0.000229	0.000824	CcSEcCtD
Vorinostat—Fatigue—Epirubicin—stomach cancer	0.000229	0.000823	CcSEcCtD
Vorinostat—Constipation—Epirubicin—stomach cancer	0.000227	0.000816	CcSEcCtD
Vorinostat—Nausea—Capecitabine—stomach cancer	0.000226	0.000814	CcSEcCtD
Vorinostat—Body temperature increased—Methotrexate—stomach cancer	0.000224	0.000806	CcSEcCtD
Vorinostat—Decreased appetite—Doxorubicin—stomach cancer	0.000214	0.000768	CcSEcCtD
Vorinostat—Gastrointestinal disorder—Doxorubicin—stomach cancer	0.000212	0.000762	CcSEcCtD
Vorinostat—Fatigue—Doxorubicin—stomach cancer	0.000212	0.000761	CcSEcCtD
Vorinostat—Constipation—Doxorubicin—stomach cancer	0.00021	0.000755	CcSEcCtD
Vorinostat—Body temperature increased—Epirubicin—stomach cancer	0.00021	0.000755	CcSEcCtD
Vorinostat—Asthenia—Methotrexate—stomach cancer	0.000204	0.000732	CcSEcCtD
Vorinostat—Pruritus—Methotrexate—stomach cancer	0.000201	0.000722	CcSEcCtD
Vorinostat—Body temperature increased—Doxorubicin—stomach cancer	0.000194	0.000698	CcSEcCtD
Vorinostat—Diarrhoea—Methotrexate—stomach cancer	0.000194	0.000698	CcSEcCtD
Vorinostat—Asthenia—Epirubicin—stomach cancer	0.000191	0.000685	CcSEcCtD
Vorinostat—Pruritus—Epirubicin—stomach cancer	0.000188	0.000675	CcSEcCtD
Vorinostat—Dizziness—Methotrexate—stomach cancer	0.000188	0.000674	CcSEcCtD
Vorinostat—Diarrhoea—Epirubicin—stomach cancer	0.000182	0.000653	CcSEcCtD
Vorinostat—Vomiting—Methotrexate—stomach cancer	0.00018	0.000649	CcSEcCtD
Vorinostat—Headache—Methotrexate—stomach cancer	0.000178	0.000639	CcSEcCtD
Vorinostat—Asthenia—Doxorubicin—stomach cancer	0.000176	0.000634	CcSEcCtD
Vorinostat—Dizziness—Epirubicin—stomach cancer	0.000176	0.000631	CcSEcCtD
Vorinostat—Pruritus—Doxorubicin—stomach cancer	0.000174	0.000625	CcSEcCtD
Vorinostat—Vomiting—Epirubicin—stomach cancer	0.000169	0.000607	CcSEcCtD
Vorinostat—Nausea—Methotrexate—stomach cancer	0.000169	0.000606	CcSEcCtD
Vorinostat—Diarrhoea—Doxorubicin—stomach cancer	0.000168	0.000604	CcSEcCtD
Vorinostat—Headache—Epirubicin—stomach cancer	0.000166	0.000598	CcSEcCtD
Vorinostat—Dizziness—Doxorubicin—stomach cancer	0.000162	0.000584	CcSEcCtD
Vorinostat—Nausea—Epirubicin—stomach cancer	0.000158	0.000567	CcSEcCtD
Vorinostat—Vomiting—Doxorubicin—stomach cancer	0.000156	0.000562	CcSEcCtD
Vorinostat—Headache—Doxorubicin—stomach cancer	0.000154	0.000553	CcSEcCtD
Vorinostat—Nausea—Doxorubicin—stomach cancer	0.000146	0.000525	CcSEcCtD
Vorinostat—HDAC2—Disease—FGFR2—stomach cancer	1.79e-05	3.61e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—VEGFA—stomach cancer	1.79e-05	3.61e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IRS2—stomach cancer	1.78e-05	3.6e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—STAT3—stomach cancer	1.77e-05	3.59e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—STAT3—stomach cancer	1.77e-05	3.58e-05	CbGpPWpGaD
Vorinostat—HDAC6—Disease—IL6—stomach cancer	1.77e-05	3.57e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—RHOA—stomach cancer	1.76e-05	3.56e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MAPK8—stomach cancer	1.75e-05	3.54e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PTGS2—stomach cancer	1.75e-05	3.54e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—ERBB2—stomach cancer	1.74e-05	3.52e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—NOS3—stomach cancer	1.74e-05	3.52e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CAV1—stomach cancer	1.73e-05	3.49e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—APOA1—stomach cancer	1.72e-05	3.48e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MTHFR—stomach cancer	1.72e-05	3.48e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CXCL8—stomach cancer	1.72e-05	3.48e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CCND1—stomach cancer	1.71e-05	3.46e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—JUN—stomach cancer	1.71e-05	3.45e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PTGS2—stomach cancer	1.7e-05	3.44e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—KRAS—stomach cancer	1.7e-05	3.43e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MAPK3—stomach cancer	1.7e-05	3.43e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MAPK3—stomach cancer	1.69e-05	3.42e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—MAPK3—stomach cancer	1.69e-05	3.42e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CDKN1B—stomach cancer	1.68e-05	3.39e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—MAPK3—stomach cancer	1.68e-05	3.39e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—SERPINE1—stomach cancer	1.68e-05	3.39e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HBEGF—stomach cancer	1.67e-05	3.38e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—HRAS—stomach cancer	1.67e-05	3.37e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—PIK3CA—stomach cancer	1.67e-05	3.37e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—PIK3CA—stomach cancer	1.67e-05	3.37e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MMP9—stomach cancer	1.66e-05	3.36e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—CDKN1A—stomach cancer	1.66e-05	3.35e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MYC—stomach cancer	1.65e-05	3.33e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MYC—stomach cancer	1.65e-05	3.33e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PRKCB—stomach cancer	1.64e-05	3.32e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IRS2—stomach cancer	1.64e-05	3.31e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL6ST—stomach cancer	1.64e-05	3.31e-05	CbGpPWpGaD
Vorinostat—NCOR1—Gene Expression—MYC—stomach cancer	1.63e-05	3.3e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—STAT3—stomach cancer	1.63e-05	3.3e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—ERBB2—stomach cancer	1.63e-05	3.29e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—VEGFA—stomach cancer	1.62e-05	3.27e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MAPK8—stomach cancer	1.62e-05	3.27e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—RHOA—stomach cancer	1.62e-05	3.27e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CDKN1B—stomach cancer	1.61e-05	3.26e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—TP53—stomach cancer	1.61e-05	3.26e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—MAPK1—stomach cancer	1.61e-05	3.26e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—EGFR—stomach cancer	1.61e-05	3.26e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—MAPK1—stomach cancer	1.61e-05	3.26e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—EGFR—stomach cancer	1.61e-05	3.25e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—MAPK1—stomach cancer	1.61e-05	3.25e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CCND1—stomach cancer	1.6e-05	3.24e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—STAT3—stomach cancer	1.6e-05	3.24e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—NOS3—stomach cancer	1.6e-05	3.23e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—JUN—stomach cancer	1.6e-05	3.23e-05	CbGpPWpGaD
Vorinostat—HDAC4—Disease—IL6—stomach cancer	1.6e-05	3.23e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CAV1—stomach cancer	1.59e-05	3.21e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—APOA1—stomach cancer	1.58e-05	3.2e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—APC—stomach cancer	1.57e-05	3.18e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—PIK3CA—stomach cancer	1.56e-05	3.15e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MAPK3—stomach cancer	1.56e-05	3.15e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MMP9—stomach cancer	1.56e-05	3.14e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—CDKN1A—stomach cancer	1.55e-05	3.13e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CXCL8—stomach cancer	1.55e-05	3.12e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ADRB2—stomach cancer	1.54e-05	3.12e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—HRAS—stomach cancer	1.54e-05	3.12e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—HRAS—stomach cancer	1.54e-05	3.11e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MAPK3—stomach cancer	1.53e-05	3.09e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—KRAS—stomach cancer	1.52e-05	3.08e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—KRAS—stomach cancer	1.52e-05	3.07e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—KRAS—stomach cancer	1.52e-05	3.07e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MYC—stomach cancer	1.52e-05	3.06e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PPP2R1A—stomach cancer	1.51e-05	3.06e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MAPK8—stomach cancer	1.51e-05	3.06e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CDKN1B—stomach cancer	1.51e-05	3.05e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IL6ST—stomach cancer	1.51e-05	3.04e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—PPARG—stomach cancer	1.5e-05	3.04e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—ERBB2—stomach cancer	1.5e-05	3.03e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—VEGFA—stomach cancer	1.49e-05	3.02e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—CDKN1A—stomach cancer	1.49e-05	3.01e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MYC—stomach cancer	1.49e-05	3.01e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—MAPK1—stomach cancer	1.48e-05	3e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—EGFR—stomach cancer	1.48e-05	2.99e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—STAT3—stomach cancer	1.48e-05	2.99e-05	CbGpPWpGaD
Vorinostat—HDAC11—Signaling Pathways—IL6—stomach cancer	1.48e-05	2.98e-05	CbGpPWpGaD
Vorinostat—HDAC8—Disease—IL6—stomach cancer	1.48e-05	2.98e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL6R—stomach cancer	1.46e-05	2.95e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—MAPK1—stomach cancer	1.46e-05	2.94e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—EGFR—stomach cancer	1.46e-05	2.94e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—APC—stomach cancer	1.45e-05	2.92e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—HRAS—stomach cancer	1.44e-05	2.91e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CCND1—stomach cancer	1.44e-05	2.91e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—JUN—stomach cancer	1.44e-05	2.9e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CXCL8—stomach cancer	1.42e-05	2.87e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MAPK3—stomach cancer	1.41e-05	2.86e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SMAD4—stomach cancer	1.41e-05	2.84e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—KRAS—stomach cancer	1.4e-05	2.83e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—PIK3CA—stomach cancer	1.4e-05	2.83e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—PIK3CA—stomach cancer	1.4e-05	2.82e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MMP9—stomach cancer	1.4e-05	2.82e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—VEGFA—stomach cancer	1.4e-05	2.82e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—PIK3CA—stomach cancer	1.4e-05	2.82e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—CDKN1A—stomach cancer	1.39e-05	2.81e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CDKN1B—stomach cancer	1.39e-05	2.8e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—STAT3—stomach cancer	1.38e-05	2.8e-05	CbGpPWpGaD
Vorinostat—HDAC9—Disease—IL6—stomach cancer	1.38e-05	2.79e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—KRAS—stomach cancer	1.38e-05	2.78e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MYC—stomach cancer	1.37e-05	2.78e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MAPK3—stomach cancer	1.37e-05	2.76e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—SERPINE1—stomach cancer	1.37e-05	2.76e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MAPK8—stomach cancer	1.36e-05	2.75e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—SERPINE1—stomach cancer	1.35e-05	2.74e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—TP53—stomach cancer	1.35e-05	2.73e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—TP53—stomach cancer	1.35e-05	2.73e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—MAPK1—stomach cancer	1.34e-05	2.72e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—EGFR—stomach cancer	1.34e-05	2.72e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IL6R—stomach cancer	1.34e-05	2.71e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FYN—stomach cancer	1.33e-05	2.7e-05	CbGpPWpGaD
Vorinostat—HDAC1—Gene Expression—MYC—stomach cancer	1.33e-05	2.69e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—STAT3—stomach cancer	1.33e-05	2.69e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CCND1—stomach cancer	1.32e-05	2.67e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MAPK3—stomach cancer	1.32e-05	2.67e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—JUN—stomach cancer	1.32e-05	2.67e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—RHOA—stomach cancer	1.32e-05	2.66e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—NOS3—stomach cancer	1.31e-05	2.64e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—HRAS—stomach cancer	1.3e-05	2.62e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—HRAS—stomach cancer	1.29e-05	2.61e-05	CbGpPWpGaD
Vorinostat—HDAC2—Hemostasis—HRAS—stomach cancer	1.29e-05	2.61e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—PIK3CA—stomach cancer	1.29e-05	2.6e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MYC—stomach cancer	1.29e-05	2.6e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MMP9—stomach cancer	1.28e-05	2.6e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—CDKN1A—stomach cancer	1.28e-05	2.59e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MAPK3—stomach cancer	1.27e-05	2.57e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—KRAS—stomach cancer	1.27e-05	2.57e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—PIK3CA—stomach cancer	1.26e-05	2.55e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—SERPINE1—stomach cancer	1.26e-05	2.54e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—MAPK1—stomach cancer	1.26e-05	2.54e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—EGFR—stomach cancer	1.26e-05	2.54e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—VEGFA—stomach cancer	1.26e-05	2.54e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—FGFR2—stomach cancer	1.25e-05	2.53e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MAPK8—stomach cancer	1.25e-05	2.52e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—STAT3—stomach cancer	1.24e-05	2.51e-05	CbGpPWpGaD
Vorinostat—HDAC3—Disease—IL6—stomach cancer	1.24e-05	2.5e-05	CbGpPWpGaD
Vorinostat—HDAC6—Signaling Pathways—IL6—stomach cancer	1.24e-05	2.5e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MYC—stomach cancer	1.24e-05	2.5e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—TP53—stomach cancer	1.22e-05	2.47e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—ERBB2—stomach cancer	1.22e-05	2.47e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—RHOA—stomach cancer	1.21e-05	2.45e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—MAPK1—stomach cancer	1.21e-05	2.44e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—EGFR—stomach cancer	1.21e-05	2.44e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—NOS3—stomach cancer	1.2e-05	2.43e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—HRAS—stomach cancer	1.19e-05	2.4e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—KRAS—stomach cancer	1.19e-05	2.4e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MAPK3—stomach cancer	1.19e-05	2.4e-05	CbGpPWpGaD
Vorinostat—HDAC3—Metabolism—PIK3CA—stomach cancer	1.17e-05	2.37e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—HRAS—stomach cancer	1.17e-05	2.36e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—PIK3CA—stomach cancer	1.17e-05	2.36e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CXCL8—stomach cancer	1.16e-05	2.34e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MYC—stomach cancer	1.15e-05	2.33e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—VEGFA—stomach cancer	1.15e-05	2.33e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IRS2—stomach cancer	1.15e-05	2.32e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—STAT3—stomach cancer	1.14e-05	2.31e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—KRAS—stomach cancer	1.14e-05	2.31e-05	CbGpPWpGaD
Vorinostat—NCOR1—Disease—IL6—stomach cancer	1.14e-05	2.3e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CDKN1B—stomach cancer	1.13e-05	2.28e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—MAPK1—stomach cancer	1.13e-05	2.28e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—EGFR—stomach cancer	1.13e-05	2.28e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—TP53—stomach cancer	1.13e-05	2.28e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—ERBB2—stomach cancer	1.12e-05	2.27e-05	CbGpPWpGaD
Vorinostat—HDAC4—Signaling Pathways—IL6—stomach cancer	1.12e-05	2.26e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CAV1—stomach cancer	1.11e-05	2.25e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—APOA1—stomach cancer	1.11e-05	2.24e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PTGS2—stomach cancer	1.1e-05	2.22e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—PIK3CA—stomach cancer	1.09e-05	2.21e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MAPK3—stomach cancer	1.09e-05	2.2e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—HRAS—stomach cancer	1.08e-05	2.18e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CCND1—stomach cancer	1.08e-05	2.18e-05	CbGpPWpGaD
Vorinostat—NCOR1—Metabolism—PIK3CA—stomach cancer	1.08e-05	2.18e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—JUN—stomach cancer	1.08e-05	2.17e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—KRAS—stomach cancer	1.07e-05	2.16e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MYC—stomach cancer	1.06e-05	2.14e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PRKCB—stomach cancer	1.06e-05	2.14e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—TP53—stomach cancer	1.06e-05	2.13e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL6ST—stomach cancer	1.05e-05	2.13e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—PIK3CA—stomach cancer	1.05e-05	2.12e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MMP9—stomach cancer	1.05e-05	2.12e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—CDKN1A—stomach cancer	1.04e-05	2.11e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN1B—stomach cancer	1.04e-05	2.1e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—MAPK1—stomach cancer	1.04e-05	2.1e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—EGFR—stomach cancer	1.04e-05	2.1e-05	CbGpPWpGaD
Vorinostat—HDAC8—Signaling Pathways—IL6—stomach cancer	1.03e-05	2.09e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MAPK8—stomach cancer	1.02e-05	2.06e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—APC—stomach cancer	1.01e-05	2.05e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—HRAS—stomach cancer	1.01e-05	2.04e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—KRAS—stomach cancer	9.81e-06	1.98e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—PIK3CA—stomach cancer	9.8e-06	1.98e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—HRAS—stomach cancer	9.7e-06	1.96e-05	CbGpPWpGaD
Vorinostat—HDAC9—Signaling Pathways—IL6—stomach cancer	9.67e-06	1.95e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—CDKN1A—stomach cancer	9.6e-06	1.94e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—TP53—stomach cancer	9.48e-06	1.92e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL6R—stomach cancer	9.41e-06	1.9e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—VEGFA—stomach cancer	9.4e-06	1.9e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—STAT3—stomach cancer	9.31e-06	1.88e-05	CbGpPWpGaD
Vorinostat—HDAC1—Disease—IL6—stomach cancer	9.29e-06	1.88e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—HRAS—stomach cancer	9.07e-06	1.83e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—PIK3CA—stomach cancer	9.01e-06	1.82e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MAPK3—stomach cancer	8.9e-06	1.8e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MAPK3—stomach cancer	8.82e-06	1.78e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—SERPINE1—stomach cancer	8.81e-06	1.78e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—TP53—stomach cancer	8.72e-06	1.76e-05	CbGpPWpGaD
Vorinostat—HDAC3—Signaling Pathways—IL6—stomach cancer	8.68e-06	1.75e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MYC—stomach cancer	8.65e-06	1.75e-05	CbGpPWpGaD
Vorinostat—HDAC2—Gene Expression—MYC—stomach cancer	8.57e-06	1.73e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—STAT3—stomach cancer	8.57e-06	1.73e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—RHOA—stomach cancer	8.5e-06	1.72e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—MAPK1—stomach cancer	8.46e-06	1.71e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—EGFR—stomach cancer	8.46e-06	1.71e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—NOS3—stomach cancer	8.41e-06	1.7e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—HRAS—stomach cancer	8.34e-06	1.68e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MAPK3—stomach cancer	8.19e-06	1.65e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—KRAS—stomach cancer	7.99e-06	1.62e-05	CbGpPWpGaD
Vorinostat—NCOR1—Signaling Pathways—IL6—stomach cancer	7.98e-06	1.61e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MYC—stomach cancer	7.96e-06	1.61e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—ERBB2—stomach cancer	7.87e-06	1.59e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—MAPK1—stomach cancer	7.79e-06	1.57e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—EGFR—stomach cancer	7.79e-06	1.57e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CXCL8—stomach cancer	7.46e-06	1.51e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—KRAS—stomach cancer	7.36e-06	1.49e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—PIK3CA—stomach cancer	7.34e-06	1.48e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN1B—stomach cancer	7.29e-06	1.47e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—TP53—stomach cancer	7.11e-06	1.44e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CCND1—stomach cancer	6.95e-06	1.4e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—JUN—stomach cancer	6.94e-06	1.4e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—HRAS—stomach cancer	6.8e-06	1.37e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—PIK3CA—stomach cancer	6.76e-06	1.37e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MMP9—stomach cancer	6.75e-06	1.36e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—CDKN1A—stomach cancer	6.72e-06	1.36e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MAPK8—stomach cancer	6.56e-06	1.33e-05	CbGpPWpGaD
Vorinostat—HDAC1—Signaling Pathways—IL6—stomach cancer	6.5e-06	1.31e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—HRAS—stomach cancer	6.25e-06	1.26e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—VEGFA—stomach cancer	6.06e-06	1.22e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—STAT3—stomach cancer	6e-06	1.21e-05	CbGpPWpGaD
Vorinostat—HDAC2—Disease—IL6—stomach cancer	5.98e-06	1.21e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MAPK3—stomach cancer	5.73e-06	1.16e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MYC—stomach cancer	5.58e-06	1.13e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—MAPK1—stomach cancer	5.45e-06	1.1e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—EGFR—stomach cancer	5.45e-06	1.1e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—KRAS—stomach cancer	5.15e-06	1.04e-05	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—PIK3CA—stomach cancer	4.73e-06	9.56e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—TP53—stomach cancer	4.58e-06	9.25e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—HRAS—stomach cancer	4.38e-06	8.85e-06	CbGpPWpGaD
Vorinostat—HDAC2—Signaling Pathways—IL6—stomach cancer	4.19e-06	8.47e-06	CbGpPWpGaD
